Marksans Pharma Ltd vs Zota Health Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Marksans Pharma Ltd is ₹ 196.35 as of 06 May 15:30 . The P/E Ratio of Marksans Pharma Ltd changed from 8.7 on March 2021 to 26.5 on March 2025 . This represents a CAGR of 24.95% over 5 yearsThe P/E Ratio of Zota Health Care Ltd changed from 84.1 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Marksans Pharma Ltd changed from ₹ 2044 crore on March 2021 to ₹ 10076 crore on March 2025 . This represents a CAGR of 37.58% over 5 yearsThe Market Cap of Zota Health Care Ltd changed from ₹ 340.16 crore on March 2021 to ₹ 2306 crore on March 2025 . This represents a CAGR of 46.64% over 5 years The revenue of Marksans Pharma Ltd for the Dec '25 is ₹ 774.57 crore as compare to the Sep '25 revenue of ₹ 741.98 crore. This represent the growth of 4.39% The revenue of Zota Health Care Ltd for the Dec '25 is ₹ 144.67 crore as compare to the Sep '25 revenue of ₹ 130.58 crore. This represent the growth of 10.79% The ebitda of Marksans Pharma Ltd for the Dec '25 is ₹ 180.89 crore as compare to the Sep '25 ebitda of ₹ 166.07 crore. This represent the growth of 8.92% The ebitda of Zota Health Care Ltd for the Dec '25 is ₹ 1.28 crore as compare to the Sep '25 ebitda of ₹ 7.96 crore. This represent the decline of -83.92% The net profit of Marksans Pharma Ltd changed from ₹ 89.07 crore to ₹ 113.69 crore over 7 quarters. This represents a CAGR of 14.97% The net profit of Zota Health Care Ltd changed from ₹ -12.72 crore to ₹ -29.64 crore over 7 quarters. This represents a CAGR of 62.16% The Dividend Payout of Marksans Pharma Ltd changed from 10.4 % on March 2021 to 19.26 % on March 2025 . This represents a CAGR of 13.12% over 5 yearsThe Dividend Payout of Zota Health Care Ltd changed from -1535 % on March 2021 to 33.23 % on March 2025 . This represents a CAGR of NaN% over 5 years .

About Marksans Pharma Ltd

Marksans Pharma Limited was formerly incorporated as 'Tasc Pharmaceuticals Limited' in April, 1982.
Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited from 10th October, 2005.
The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
Marksans Pharma Limited (formerly M/s.

About Zota Health Care Ltd

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products.
The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat.
The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving India's pharmaceutical industry a boost. The Company has three business verticals: Marketing-a traditional business vertical, and driving business verticals - Exports and Retail harmacy Chain.
Through its chain, Davaindia, the largest private-sector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business.

FAQs for the comparison of Marksans Pharma Ltd and Zota Health Care Ltd

Which company has a larger market capitalization, Marksans Pharma Ltd or Zota Health Care Ltd?

Market cap of Marksans Pharma Ltd is 8,897 Cr while Market cap of Zota Health Care Ltd is 4,559 Cr

What are the key factors driving the stock performance of Marksans Pharma Ltd and Zota Health Care Ltd?

The stock performance of Marksans Pharma Ltd and Zota Health Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Marksans Pharma Ltd and Zota Health Care Ltd?

As of May 6, 2026, the Marksans Pharma Ltd stock price is INR ₹196.35. On the other hand, Zota Health Care Ltd stock price is INR ₹1316.4.

How do dividend payouts of Marksans Pharma Ltd and Zota Health Care Ltd compare?

To compare the dividend payouts of Marksans Pharma Ltd and Zota Health Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.